adiotherapy, alone or in combination with surgery or chemotherapy, plays a critical role in the management of non-small cell lung cancer (NSCLC). 1 However, tumor radioresistance, including intrinsic radioresistance before treatments and acquired radioresistance during radiotherapy, is one of the main obstacles to promote the efficacy of radiotherapy for NSCLC. Accumulating evidence suggests that radioresistance is often correlated with some genes, such as p53 2 and epidermal growth factor receptor (EGFR). 3 Although such discoveries have contributed to a partial understanding of the mechanisms for cellular radioresistance, the comprehensive functional mechanisms remain largely elusive. This may be quite reasonable since the mechanisms of radio-resistance are a complex multigene interaction. Gene expression profiling analysis can increase our understanding of the molecular mechanisms and pathways that involve radioresistance using cDNA microarray. Some investigators have identified a set of genes related to inherent radioresistance by comparing expression profiles of radiosensitive and radioresistant tumors samples before treatment using microarray, 4 whereas others have identified differentially expressed genes of acquired radioresistant tumor cells during the radiation treatments using gene chips, including esophageal cancer and pancreatic cancer. 5, 6 To our knowledge, there has been no information about the global gene analyses of acquired radioresistant NSCLC by fractionated ionizing radiation (FIR). The main purpose of this study was to identify gene expression profiles between Anip973 and acquired radioresistant phenotype by FIR, Anip973R using oligonucleotide microarrays in order to provide the new molecular evidences for radio-resistance.
METHODS

Cell culture
The human lung adenocarcinoma cell line Anip973 was cultured as monolayers in RPMI-1640 medium (GIBCO/BRL, USA) supplemented with 10% heatinactivated fetal bovine serum, penicillin (100 U/ml) and streptomycin (100 µg/ml), and maintained at 37°C in a humidified atmosphere of 5% CO 2 and 95% air.
Generation of radioresistant cells
Anip973 cells (1×10 6 ) were plated in 75 cm 2 culture flasks and irradiated with 4 Gy of X-ray using high energy liner accelerator (Varian 600C, USA) at a dose rate of 3 Gy per minute when the cells grew to approximately 60% confluence of flask. Immediately after irradiation, the culture medium was renewed and then the cells were returned to the incubator. When Anip973 cells incubated to approximately 90% confluence, they were trypsinized, counted and passaged into new culture flasks. The cells were treated with 4 Gy again when they reached about 60% confluence. These procedures were repeated 15 times to the total doses of 60 Gy for 6 months. The parental cells were trypsinized, counted and passaged under the same conditions without ionizing irradiation. For all assays on ionizing cells, one month was an interval between the last irradiation and other tests for obtaining stable radioresistant cells.
Clonogenic assay for radiosensitivity
The cells were seeded into 25 cm 2 culture flasks with 200-10 000 cells/dish according to the variable doses of irradiation. On the following day the cells were irradiated and incubated for 2 weeks at 37°C in a 5% CO 2 environment to allow the colony formation. The colonies were fixed with pure ethanol and stained with 1% crystal violet. Colonies consisting of 50 or more cells were counted as clonogenic survivors. Surviving fractions were calculated by normalizing to the plating efficiency of the absent control cells. The triplicate experiments were done independently. The average data were fitted into single-hit multitarget formula: S=1-(1-e -D/Do ) N where S is the fraction of cells surviving a dose, D. D0, called the "mean lethal dose", is the dose on the straight-line portion of the survival curve to decrease the survival to 37%. The "quasi-threshold dose" or D q , which is the intercept of the extrapolated high dose, was also calculated. N is referred to the extrapolation number which is a parameter to measure the width of shoulder of the survival curve.
Flow cytometry analysis for cell cycle and apoptosis
The exponential growth cells were harvested and washed twice with PBS, followed by fixation in 70% cold ethanol diluted in PBS on ice for 30 minutes at 4°C. The cells were then washed with PBS and incubated with propidium iodide (PI) for 30 minutes at room temperature. Cell cycles were analyzed using a Coulter Epics EE flow cytometer (Beckman Coulter, USA).
The cells were irradiated with 2 Gy and harvested 24 hours after irradiation. Apoptosis was assessed by Annexin V-FITC/PI staining according to the manufacturer's protocol (Becton Dickinson, USA). The cells were then analyzed with a FACSAria flow cytometer (Becton Dickinson).
Total RNA extraction
Total RNA was extracted from cells with Trizol Reagent Kit (Invitrogen, USA) according to the manufacturer's instructions. The extracted RNA was then purified by NucleoSpin ® RNA clean-up kit (Macherey-Nagel, Germany). The RNA quality was validated using RNA electrophoresis and the concentration was determined with a spectrophotometer.
Oligonucleotide microarray analysis
The commercially available 22K Human Genome Array including 21 522 human genes was purchased from CapitalBio Corporation (Beijing, China). Labeling, hybridization, washing and scanning were performed. In brief, double-stranded cDNA was synthesized with 5 µg of total RNA using T7-(oligo) dT promoter primer. The purified cDNA was transcribed into cRNA using T7 RNA polymerase. Next, 2 µg of cRNA was reverse transcribed to generate cDNA using MMLV reverse transcriptase (Invitrogen). The cDNA was synthesized with 2 µg of cRNA using MMLV reverse transcriptase again, which fluorescently labeled by Cy5 or Cy3-CPT with Klenow enzyme (Takara, Japan). During this process, the radioresistant cell line cDNA was labeled by Cy5-CPT and the parent cell line was labeled by Cy3-CPT as a control, respectively. The radioresistant and parent samples were quantitatively adjusted and mixed into 30 µl hybridization solution at 42°C overnight. After hybridization the microarray was washed with two consecutive washing solutions (0.2% sodium dodecyl sulfate, 2×SSC at 42°C for 5 minutes, and 0.2% SSC for 5 minutes at room temperature). These arrays were scanned with a LuxScan 10KA confocal laser scaner (CapitalBio Corporation, China), and the obtained images were analyzed using LuxScan 3.0 (CapitalBio Corporation), which employed the LOWESS normalization method.
Oligonucleotide microarray data analysis
The triplicate experiments of hybridization were independently carried out with the same sets of Cy5-and Cy3-labeled probes to improve the accuracy of data analysis. The intensity of each gene was measured and the ratios of Cy5 to Cy3 for each individual gene were computed, respectively. The differentially expressed genes that displayed average ratio in triplicate tests greater than 2.0-fold up-regulated or less than 0.5-fold down-regulated were picked up. Hierarchical clustering and tree diagram were generated by Cluster and Tree-View software.
Quantitative RT-PCR
To further confirm the results of cDNA microarray data, quantitative RT-PCR was performed using the LightCycler-FastStart DNA Master SYBR Green I Kit (Roche Applied Science) according to the manufacturer's instructions. Briefly, 5 µg of total RNA was reverse transcripted into cDNA using Superscript II reverse transcriptase (Invitrogen). A reaction master mixture was prepared as follows: 13.8 µl of water, 1.6 µl of MgCl 2 (3 mmol/L), 0.8 µl of each primer (10 mmol/L), 2 µl of Fast Start DNA Master SYBR Green I and 1 µl cDNA in a 20 µl final volume. The primer sequences were listed in Table 1 . The real-time RT-PCR program was as follows: initiation with 10 minutes of denaturation at 95°C, followed by 40 cycles of amplification with 15 seconds of denaturation at 95°C, 5 seconds at 56°C for annealing, and 15 seconds of extension at 72°C. Melting curves and 1.5% agarose gel electrophoresis were produced to validate the specificity of the amplified products. The comparative threshold cycle (CT) method was used to calculate amplification fold. β-actin was used as a reference control gene to normalize the expression value of each gene. Triplicate replicates were performed for each gene and average expression value was computed for subsequent analysis. Primers from 5' to 3' 
Statistical analysis
Student's t test was used to determine the statistical significance of cell cycle distributions and apoptosis between groups. P values less than 0.05 were considered statistically significant. Data analysis was performed using the SPSS software, version 11.5.
RESULTS
Radiosensitivity analysis
After 6 months of fractionated irradiation with total doses of 60 Gy, stable radio-resistant cells, designated Anip973R, were obtained. Their survival curve parameters are listed in Table 2 . All parameters of Anip973R are greater than those of the parent cell, Anip973, special D q and SF2 (survival fraction in a dose of 2 Gy), indicating that Anip973R has a greater capability for potentially lethal damage repair compared with Anip973. Figure 1 depicts the cell survival curves derived from colony formation assays for Anip973R and Anip973. Each point on the survival curve represents the mean surviving fraction from the triplicate experiments. Comparing with Anip973, Anip973R's survival curve demonstrated a broader shoulder in low dose area, indicating that the Anip973R cells were more radiation-resistant than the Anip973 cells.
Cell cycle and apoptosis analysis
The fractions of G 1 , S and G 2 /M cells were (63.22±1.73)%, (23.25±0.79)% and (13.53±1.23)% for Anip973R, respectively. Corresponding fractions were (59.70±2.36)%, (24.61±0.87)% and (15.69±2.02)% for Anip973. In Anip973R cells, the percentage of cells in G 1 phase was greater than that of Anip973 cells (P <0.05), whereas the percentage of cells in S was decreased significantly than that of Anip973 (P <0.05). However, in G 2 /M phase populations were similar in both cells (P >0.05), indicating that alteration of cell cycle distributions cannot be interpreted completely by decreased radio-sensitivity of resistant cells (Figure 2 ).
Twenty-four hours after irradiation, evaluation of apoptosis indicated that there was a significant decrease in apoptosis in Anip973R compared with the parental cells (P <0.05). Therefore, we considered Anip973R as radioresistant (Figure 3 ).
Identification of differentially expressive genes
We used an oligonucleotide microarray including 21 522 human genes to screen altered genes of Anip973 and Anip973R. We identified 102 genes as differentially expressed between Anip973 and Anip973R ( Figure 4 ). As seen in Table 3 and Table 4 , 59 genes expression was higher and, in other 43 genes, expression was lower in Anip973R cells compared with Anip973 cells. Up-regulated genes were associated with cell growth (IGFBP3, FGB, and TGFβI), DNA damage repair (DDB2), extracellular matrix (LOX, FBN1, and DCN), inflammatory response (ANXA1, PROCR), cell adhesion (CDH2), phosphatidylinositol signaling system (DGKA), and cell motility (FN1). Down-regulated genes were associated with immune response (CD83, EBI3, and SPINK5), metabolism (INHBB, SOAT1), cytoskeleton (KRT17, FGF12), electron transport (AKR1C4), and calcium signaling pathway (TNNC1).
QRT-PCR analysis
To validate the precision of our microarray data, quantitative RT-PCR was performed using the same RNA sample as that used in the oligonucleotide microarray. The expression ratio measured by the microarray and QRT-PCR for 11 genes are shown in Figure 5 . Although there were small differences in the fold-change values between the microarray and the QRT-PCR, these results were generally highly related, strongly supporting the reliability of our array.
DISCUSSION
Tumor radio-resistance remains a critical obstacle in clinical radiotherapy or combined radiochemotherapy for NSCLC. However, the nature of acquired radioresistance during and after irradiation is still debated. 6 It has been known that many oncogenes may involve radioresistance, but the interpretation using a single gene for radioresistance may not be completely accurate and may be contradictory in some reports. 2, 7 cDNA microarray provides an opportunity for identifying different genes and signaling events involved in tumor radioresistance simultaneously. To investigate clinically observed radioresistance, we obtained stable radioresistant cells, Anip973R, by regimens of FIR in vitro. Comparing Anip973R with their parent cells, Anip973, we could truly examine genes related with radioresistance. In the present study, we identified 59 up-regulated and 43 down-regulated genes comparing Anip973R with Anip973. It is well known that radioresistance is associated with DNA damage repair, apoptosis, and cell cycle checkpoints. Several of the 102 genes, such as CRYAB and DDB2, have been reported to be related to above features, 8, 9 but others are novel. These genes involve many malignant characteristics of cancer cells such as poor prognosis, metastasis, and invasion. However, the accurate function of these novel genes involving in radio-resistance remains unclear, so radio-resistance is worth being investigated further.
Genes up-regulated in Anip973R cells include DDB2, LOX, CDH2, CRYAB and DCN. DNA damage binding protein 2 (DDB2), which codes for the p48 subunit of xeroderma pigmentosum group E (XPE), is one of the major DNA repair proteins involved in the nucleotide excision repair (NER) pathway. It is known that injury to DNA is the primary mechanism by which ionizing radiation kills cells and increased DNA damage repair contributes to radioresistance. DDB2 plays a crucial role in repair of ultraviolet and ionizing radiation DNA damage through binding tightly to damage chromatin. 10 Furthermore, Sun et al 11 have indicated that overexpression of DDB2 attenuates UV-induced apoptosis in DDB2-depleted Hela cells. Alpha B-crystallin (CRYAB) is a member of the small heat shock protein family. Recent reports have indicated that CRYAB negatively regulates cancer cells apoptosis induced by various stimuli, including DNA-damaging agents and growth factor deprivation, by inhibiting autoproteolytic maturation of caspase-3. 8 Furthermore, alpha B-crystallin interacts directly with the proapoptotic Bcl-2 family members Bax and Bcl-Xs in vitro and in vivo and prevents their translocation to the mitochondria and hence decreases apoptosis.
12 CRYAB was also identified as a potential oncogene inducing neoplastic-like changes such as loss of polarity, increased proliferation, and increased migration and invasion, except for diminished apoptosis. Moreover, the over-expression of CRYAB correlates inversely with disease-specific survival, and it is an independent marker for poor prognosis in human cancers. 13 Recent studies have demonstrated that N-cadherin (CDH2) expression correlates both with invasion and mobility and plays a direct role in promoting metastasis in various cancers. 14, 15 Interestingly enough, N-cadherin was upregulated in our Anip973R, whereas E-cadherin was downregulated in radioresistant esophageal cancers obtained by FIR. 5 Clinical studies have shown that inverse expressions of them are associated with metastasis and poor prognosis. 16 Moreover, Tran et al 17 demonstrated that N-cadherin enhanced the level of Bcl-2 through activating a phosphoinositide 3-kinase/AKT (PI3K/AKT) signal pathway, which in turn suppressed apoptosis in prostate carcinoma cells. Lysyl oxidase (LOX) has been shown to be attributed to invasion, metastasis and lower overall survival in vitro and in vivo. Erler et al 18 validated LOX as a hypoxia-responsive gene and found it to be up-regulated expression by hypoxia-inducible factor-1 (HIF-1). Furthermore, Lox and fibronectin 1 (FN1) were upregulated simultaneously in the Anip973R microarray data set we analyzed. FN was reported to regulate LOX activity by strengthening its proteolytic capability. 19 However, their interactive mechanism for acquired radioresistance is not clear. Decorin, a small leucine-rich proteoglycan, is a biological ligand for the epidermal growth factor receptor (EGFR). It stimulates phosphorylation of the EGF receptor. 20 There is increasing evidence that high-level expression of EGFR is positively corelated with tumor resistance to radiation. 21 Moreover, decorin is an important antiapoptotic factor in a variety of cell systems. 22 More interestingly, decorin was upregulated in radio-resistant squamous cell carcinoma of the head and neck (SCCHN) patients as shown by microarray analysis. 4 Recent studies have shown that decorin can arrest cells at the G1 phase that is a relative radioresistant cell cycle. 23 Our results also display that Anip973 cells without irradiation have relatively fewer cells in G 1 phase compared with those in Anip973R. These functions suggest, but certainly do not prove, that decorin contributes to radioresistance after FIR.
Genes down-regulated in Anip973R cells include GBP-1 and CD83. Guanylate binding protein-1 (GBP-1), induced by inflammatory cytokines, has been detectable in various endothelial cells, including the lung, heart, spleen and uterus. 24 Lubeseder-Martellato et al 24 reported that GBP-1 expression was inversely associated with cell proliferation in vessel endothelial cells of Kaposi's sarcoma (KS) in vivo. Furthermore, Guenzi et al 25 reported that GBP-1 played a role in inhibiting endothelial cells (ECs) invasion and proliferation and further inhibiting angiogenesis in ECs. Angiogenesis is attributed to the formation of resistance of tumor cells to ionizing radiation. Some preclinical studies have demonstrated that the combination of radiotherapy and angiogenic blockade enhances the therapeutic ratio of ionizing radiation by targeting both tumor cells and tumor vessels. 26 To our knowledge, there have been no reports of a relation between radioresistance and GBP-1. CD83, a marker of mature human dendritic cells, belongs to a member of the immunoglobulin superfamily. Yang et al 27 reported that melanoma cells transfected to express CD83 induce a tumor-destructive immune response, indicating that CD83 is highly associated with antitumor immunity. On the other hand, Iwamoto et al 28 reported that breast cancer patients with CD83 negative had an unfavorable relapse-free and overall survival than positive patients, and that it was inversely correlated with lymph node metastasis and with tissue expression of VEGF. Miyagawa et al 29 found the similar results in patients with metastatic liver tumors. More interestingly, they found that patients with fewer numbers of CD83 positive cells had significantly decreased apoptotic cancer cells. However, the explicit mechanism between radio-resistance and CD83 remains unclear.
Up to now, the precise mechanism of the acquired radioresistance of Anip973R by FIR is still unclear, but our microarray results may imply some impossible mechanism involving the acquired radio-resistance such as DNA damage repair, apoptosis, proliferation, angiogenesis, and invasion. Further studies are needed to elucidate these genes' potential function for radioresistance. Although one limitation of our study is that NSCLC cell-line was used in vitro not in vivo, which might ignore the potential role of the tumor microenvironment in irradiation resistance, the data strongly implicate novel therapeutic targets for overcoming radio-resistance.
